Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NVCR
NVCR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVCR News
Potential Analysis of Small Biotech Stocks
5d ago
Fool
NovoCure Q1 2026 Earnings Call Highlights
Apr 30 2026
seekingalpha
NovoCure Shares Surge 22% After Strong Q1 Revenue and Upgraded Outlook
Apr 30 2026
seekingalpha
NovoCure Q1 Earnings Beat Expectations with Revenue Growth
Apr 30 2026
seekingalpha
NovoCure Q1 Earnings Announcement Scheduled
Apr 29 2026
seekingalpha
Wedbush Reiterates Ratings for Multiple Biotech Firms
Apr 17 2026
NASDAQ.COM
Novocure's Tumor Treating Fields Trial Achieves Primary Endpoint
Mar 26 2026
seekingalpha
Novocure Reports Positive Results in Cancer Therapy Trial
Mar 26 2026
stocktwits
Novocure Reports Positive Phase 2 Trial Results for mPDAC Treatment
Mar 26 2026
NASDAQ.COM
Novocure to Participate in Global Healthcare Conference
Feb 27 2026
Businesswire
Novocure to Participate in Global Healthcare Conference
Feb 27 2026
Newsfilter
NovoCure Reports Record Revenue and Growth in 2025 Earnings Call
Feb 26 2026
seekingalpha
NovoCure Q4 Earnings Beat Expectations with Positive Guidance
Feb 26 2026
seekingalpha
NovoCure Q4 Earnings Announcement Scheduled
Feb 25 2026
seekingalpha
Oncolytics Biotech Receives FDA Fast Track Designation for Cancer Treatment
Feb 17 2026
PRnewswire
Oncolytics Biotech Receives FDA Fast Track Designation for Cancer Treatment
Feb 17 2026
PRnewswire
Show More News
